ArticleTheranostics2021

KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1.

Wenxue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.